Please sign in to follow a disease.
Nevro Corp
Clinical trials sponsored by Nevro Corp, explained in plain language.
A medical device company focused on spinal cord stimulation for chronic pain.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New pulse dose setting may improve pain relief for spinal cord stimulator users
Symptom relief OngoingThis study tests whether a new 'pulse dose' setting on an implanted spinal cord stimulator can improve pain relief and satisfaction for people with chronic, hard-to-treat back or leg pain. Participants already have a Nevro Senza or Omnia device and will try different pulse dose s…
Phase 4 • Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Shocking nerve pain away: new device trial for diabetic neuropathy
Symptom relief OngoingThis study tests whether a device that sends mild electrical pulses to the spinal cord (10 kHz SCS) can reduce pain and improve nerve function in people with painful diabetic neuropathy. About 143 participants will either get standard medical care alone or the device plus standar…
Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Spinal implant offers new hope for diabetic leg pain
Symptom relief OngoingThis study looks at how well a spinal cord stimulator works in real-world settings for people with long-term leg pain caused by diabetic neuropathy. About 500 participants will receive the implant and be followed for a year. Researchers will measure pain relief, quality of life, …
Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC